当前位置:首页 - 行情中心 - 天臣医疗(688013) - 财务分析 - 现金流量表

天臣医疗

(688013)

  

流通市值:46.66亿  总市值:46.66亿
流通股本:8115.56万   总股本:8115.56万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金162,653,794.3474,632,957.61287,753,394.5208,678,676.28
  收到的税费返还4,572,751.96-4,754,268.114,754,268.11
  收到其他与经营活动有关的现金796,176.11212,976.635,771,719.2312,549,260.51
  经营活动现金流入小计168,022,722.4174,845,934.24298,279,381.84225,982,204.9
  购买商品、接受劳务支付的现金62,577,830.6627,888,650.23122,823,492.9396,688,415.14
  支付给职工以及为职工支付的现金40,136,194.8822,794,451.7864,406,593.2248,534,231.2
  支付的各项税费7,017,832.121,867,725.5219,215,789.6313,599,986.45
  支付其他与经营活动有关的现金21,312,582.889,164,805.4138,424,534.3628,638,876.71
  经营活动现金流出小计131,044,440.5461,715,632.94244,870,410.14187,461,509.5
  经营活动产生的现金流量净额36,978,281.8713,130,301.353,408,971.738,520,695.4
二、投资活动产生的现金流量:
  收回投资收到的现金435,055,911.8239,854,418.8996,582,579.7562,796,926
  取得投资收益收到的现金2,346,670.951,316,608.36,565,162.473,156,822.93
  收到的其他与投资活动有关的现金200,000200,00010,490,000-
  投资活动现金流入小计437,602,582.75241,371,027.11,013,637,742.17565,953,748.93
  购建固定资产、无形资产和其他长期资产支付的现金44,898,773.0615,298,553.2541,940,427.3229,898,532.29
  投资支付的现金342,690,203.7253,062,6731,116,951,818.5738,384,466
  支付其他与投资活动有关的现金9,190,000140,0001,950,000-
  投资活动现金流出小计396,778,976.76268,501,226.251,160,842,245.82768,282,998.29
  投资活动产生的现金流量净额40,823,605.99-27,130,199.15-147,204,503.65-202,329,249.36
三、筹资活动产生的现金流量:
  吸收投资收到的现金22,715,013.314,744,00027,156,109.8527,156,109.85
  取得借款收到的现金32,972,965.6220,079,920.9749,723,908.6935,051,792.69
  筹资活动现金流入小计55,687,978.9234,823,920.9776,880,018.5462,207,902.54
  偿还债务支付的现金22,853,497.62-49,723,908.6935,051,792.69
  分配股利、利润或偿付利息支付的现金81,084,834.4939,587,64738,305,042.53129,370.87
  支付其他与筹资活动有关的现金1,655,010.92326,645.6442,508,222.3640,573,600.05
  筹资活动现金流出小计105,593,343.0339,914,292.64130,537,173.5875,754,763.61
  筹资活动产生的现金流量净额-49,905,364.11-5,090,371.67-53,657,155.04-13,546,861.07
四、汇率变动对现金及现金等价物的影响6,642,598.51,550,362.0945,016.56456,617.9
五、现金及现金等价物净增加额34,539,122.25-17,539,907.43-147,407,670.43-176,898,797.13
  加:期初现金及现金等价物余额64,125,887.5864,125,887.58211,533,558.01211,533,558.01
  期末现金及现金等价物余额98,665,009.8346,585,980.1564,125,887.5834,634,760.88
补充资料:
  净利润48,211,574.09-51,894,845.59-
  资产减值准备281,134.21-338,423.76-
  固定资产和投资性房地产折旧4,985,599.56-9,117,902.79-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧4,985,599.56-9,117,902.79-
  无形资产摊销299,355.6-524,968.35-
  长期待摊费用摊销59,593.67-153,541.52-
  处置固定资产、无形资产和其他长期资产的损失-686.5---
  固定资产报废损失10,313.41-1,051.87-
  公允价值变动损失-1,669,079.24-1,891,985.38-
  财务费用-462,899.01-233,643.11-
  投资损失-2,346,670.95--6,565,162.47-
  递延所得税-806,104.87-1,786,650.8-
  其中:递延所得税资产减少-850,979.4-1,336,417.52-
    递延所得税负债增加44,874.53-450,233.28-
  存货的减少-11,318,711.59--1,903,788.14-
  经营性应收项目的减少-14,475,826.42--4,162,392.43-
  经营性应付项目的增加9,828,555.52--12,657,917.89-
  其他2,978,626.58-11,929,815.87-
  现金的期末余额98,665,009.83-64,125,887.58-
  减:现金的期初余额64,125,887.58-211,533,558.01-
  现金及现金等价物的净增加额34,539,122.25--147,407,670.43-
公告日期2025-08-272025-04-282025-04-282024-10-30
审计意见(境内)标准无保留意见
TOP↑